Become a credit card member today!
Vetmedin Chewable Tablets for Dogs 1.25 mg, Count of 50
Description
VETMEDIN (pimobendan) Chewable Tablets is an inodilator approved by the FDA1 that is demonstrated to delay the onset of congestive heart failure (CHF) in dogs with Stage B2 preclinical myxomatous mitral valve disease (MMVD), and manages the signs of mild, moderate, or severe CHF in dogs due to clinical MMVD or dilated cardiomyopathy (DCM). 2,3 Given every 12 hours, its unique dual mode of action reduces the preload and afterload on the heart while improving contractility of the heart muscle.1 Pimobendan, the active ingredient in VETMEDIN, reduces stress on the heart and increases cardiac output without raising oxygen or energy consumption. When used as directed, VETMEDIN is demonstrated to prolong the symptom-free time in MMVD, and improve quality of life and survival time in dogs in heart failure due to MMVD. Ask your veterinarian if VETMEDIN is right for your dog.
- - The only medication approved by the FDA to delay the onset of CHF in dogs with Stage B2 preclinical MMVD.2,3,4
- - When used as directed for dogs with heart failure due to MMVD, it is demonstrated to increase survival time and improve quality of life.2,3
- - Available as a highly palatable, beef-flavored chewable tablet in 4 convenient dosing sizes (1.25 mg, 2.5 mg, 5 mg, and 10 mg) for small, medium, large, and extra-large dogs
- - References: 1. VETMEDIN (pimobendan) Chewable Tablets (Freedom of Information Summary; NADA 141-273). St. Joseph, MO: Boehringer Ingelheim Vetmedica, Inc.; 2007. 2. Haggstrom J, Boswood A, O'Grady M, et al. Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease: the QUEST study. J Vet Intern Med. 2008;22(5):1124-1135. 3. Lombard CW, Jons O, Bussadori CM; for the VetSCOPE Study. Clinical efficacy of pimobendan versus benazepril for the treatment of acquired atrioventricular valvular disease in dogs. J Am Anim Hosp Assoc. 2006;42(4):249-261. 4. Keene et al ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs. J Vet Intern Med 2019. 5. Boswood A., Haggstrom J., Gordon S.G., et al. Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study-A Randomized Clinical Trial
Please note that the product information displayed is provided by manufacturers, suppliers and other third parties and is not independently verified by Petco.
Specifications
| SKU | 3016841 |
|---|---|
| Primary Brand | Vetmedin |
| Days to Ship | Product Will Ship Upon Verification of Prescription, Usually 2-5 Business Days |
| Personalized Item flag | No |
|---|
VETMEDIN (pimobendan) Chewable Tablets should be administered orally at a total daily dose of 0.23 mg/lb (0.5 mg/kg) body weight, using a suitable combination of whole or half tablets. The total daily dose should be divided into 2 portions that are not necessarily equal, and the portions should be administered approximately 12 hours apart (i.e., morning and evening). The tablets are scored and the calculated dosage should be provided to the nearest half tablet increment.
Federal law restricts this drug to use by or on the order of a licensed veterinarian. The safety of VETMEDIN (pimobendan) Chewable Tablets has not been established in dogs with asymptomatic heart disease or in heart failure caused by etiologies other than MMVD or DCM. The safe use of VETMEDIN has not been evaluated in dogs younger than 6 months of age, dogs with congenital heart defects, dogs with diabetes mellitus or other serious metabolic diseases, dogs used for breeding, or pregnant or lactating bitches.
Description
VETMEDIN (pimobendan) Chewable Tablets is an inodilator approved by the FDA1 that is demonstrated to delay the onset of congestive heart failure (CHF) in dogs with Stage B2 preclinical myxomatous mitral valve disease (MMVD), and manages the signs of mild, moderate, or severe CHF in dogs due to clinical MMVD or dilated cardiomyopathy (DCM). 2,3 Given every 12 hours, its unique dual mode of action reduces the preload and afterload on the heart while improving contractility of the heart muscle.1 Pimobendan, the active ingredient in VETMEDIN, reduces stress on the heart and increases cardiac output without raising oxygen or energy consumption. When used as directed, VETMEDIN is demonstrated to prolong the symptom-free time in MMVD, and improve quality of life and survival time in dogs in heart failure due to MMVD. Ask your veterinarian if VETMEDIN is right for your dog.
- - The only medication approved by the FDA to delay the onset of CHF in dogs with Stage B2 preclinical MMVD.2,3,4
- - When used as directed for dogs with heart failure due to MMVD, it is demonstrated to increase survival time and improve quality of life.2,3
- - Available as a highly palatable, beef-flavored chewable tablet in 4 convenient dosing sizes (1.25 mg, 2.5 mg, 5 mg, and 10 mg) for small, medium, large, and extra-large dogs
- - References: 1. VETMEDIN (pimobendan) Chewable Tablets (Freedom of Information Summary; NADA 141-273). St. Joseph, MO: Boehringer Ingelheim Vetmedica, Inc.; 2007. 2. Haggstrom J, Boswood A, O'Grady M, et al. Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease: the QUEST study. J Vet Intern Med. 2008;22(5):1124-1135. 3. Lombard CW, Jons O, Bussadori CM; for the VetSCOPE Study. Clinical efficacy of pimobendan versus benazepril for the treatment of acquired atrioventricular valvular disease in dogs. J Am Anim Hosp Assoc. 2006;42(4):249-261. 4. Keene et al ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs. J Vet Intern Med 2019. 5. Boswood A., Haggstrom J., Gordon S.G., et al. Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study-A Randomized Clinical Trial
Please note that the product information displayed is provided by manufacturers, suppliers and other third parties and is not independently verified by Petco.
Specifications
| SKU | 3016841 |
|---|---|
| Primary Brand | Vetmedin |
| Days to Ship | Product Will Ship Upon Verification of Prescription, Usually 2-5 Business Days |
Reviews
Rating Snapshot
Review this Product
Customers say
Customers overwhelmingly praise this flea and tick prevention product for its consistent effectiveness, with most reporting zero sightings for weeks or months after application. Many highlight the simple topical application process and appreciate its reliability, especially for dogs in outdoor or tick-prone environments. Long-term users express strong trust and loyalty, frequently recommending it to others. A few customers report temporary mild itching in sensitive dogs within 24-48 hours, though symptoms typically subside quickly. Overall, reviewers consider it highly effective and dependable for protecting their pets.
Most Helpful Favorable Review
Vetmedin Not In Original Bottle
Folden
7 years ago
Product does not come as shown. The tablets are counted out and placed in anothe...
Show Full Review
14 PEOPLE FOUND THIS HELPFUL
Show Reviews:
5
and
4
Most Helpful Critical Review
Product does not come in original Vetmedin package
SandyCn
6 years ago
This review is for the 2.5mg chewable tablets I ordered. The product came in a g...
Show Full Review
10 PEOPLE FOUND THIS HELPFUL
Show Reviews:
3
2
and
1
Customer Images
Filter Reviews
207 Ratings-Only Reviews
Poor
No, I do not recommend this product.
It's working for my dog.
Yes, I recommend this product.
Heart failure meds
Yes, I recommend this product.
FRONTLINE® Shield for Dogs (XS, 5-10 lbs)
Originally posted on Frontline Sampling Community
Good
Originally posted on Frontline Sampling Community
FRONTLINE Shield for Dogs Does a Good Job!
Originally posted on Frontline Sampling Community
Worked well
Originally posted on Frontline Sampling Community
Vetmedin
Yes, I recommend this product.
